Clearstead Advisors’s CareTrust REIT CTRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.1K Buy
1,639
+1,005
+159% +$39.5K ﹤0.01% 1407
2026
Q1
$23.2K Buy
634
+438
+223% +$16.8K ﹤0.01% 1423
2025
Q4
$7.09K Hold
196
﹤0.01% 1953
2025
Q3
$6.8K Sell
196
-597
-75% -$19.6K ﹤0.01% 2050
2025
Q2
$24.3K Buy
793
+196
+33% +$5.65K ﹤0.01% 1542
2025
Q1
$17.1K Hold
597
﹤0.01% 1469
2024
Q4
$16.1K Hold
597
﹤0.01% 1454
2024
Q3
$18.4K Buy
597
+315
+112% +$8.92K ﹤0.01% 1443
2024
Q2
$7.08K Buy
+282
New +$6.98K ﹤0.01% 1617

Other funds holding CTRE

Clearstead Advisors's CTRE Position: Q2 2026 in Review

Clearstead Advisors increased its CareTrust REIT (CTRE) stake by 159% in Q2 2026, buying an estimated $39.5K and bringing the position to 1,639 shares worth $66.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Clearstead Advisors first reported a position in CTRE in Q2 2024 and has held it in 9 quarters since. 512 funds tracked by Wall St. Rank hold CTRE as of Q2 2026.

  • Clearstead Advisors held 1,639 shares of CareTrust REIT worth $66.1K as of Q2 2026.
  • Clearstead Advisors bought 1,005 CareTrust REIT shares in Q2 2026, an estimated $39.5K.
  • CareTrust REIT made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1407 holding.
  • Clearstead Advisors first reported a position in CareTrust REIT in Q2 2024 and has held it in 9 quarters since.
  • 512 funds tracked by Wall St. Rank held CareTrust REIT as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.